Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emerging drugs for the treatment of soft tissue sarcomas.
Cassier PA, Dufresne A, Fayette J, Alberti L, Ranchere D, Ray-Coquard I, Blay JY. Cassier PA, et al. Among authors: fayette j. Expert Opin Emerg Drugs. 2007 Mar;12(1):139-53. doi: 10.1517/14728214.12.1.139. Expert Opin Emerg Drugs. 2007. PMID: 17355219 Review.
ET-743: a novel agent with activity in soft tissue sarcomas.
Fayette J, Coquard IR, Alberti L, Ranchère D, Boyle H, Blay JY. Fayette J, et al. Oncologist. 2005 Nov-Dec;10(10):827-32. doi: 10.1634/theoncologist.10-10-827. Oncologist. 2005. PMID: 16314293 Free article. Review.
[News of the year 2005 in sarcomas].
Fayette J, Méeus P, Sunyach MP, Thiesse P, Ray Coquard I, Blay JY. Fayette J, et al. Bull Cancer. 2006 Jan;93(1):83-9. Bull Cancer. 2006. PMID: 16455510 Free article. Review. French.
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis.
Bay JO, Ray-Coquard I, Fayette J, Leyvraz S, Cherix S, Piperno-Neumann S, Chevreau C, Isambert N, Brain E, Emile G, Le Cesne A, Cioffi A, Kwiatkowski F, Coindre JM, Bui NB, Peyrade F, Penel N, Blay JY; Groupe Sarcome Français. Bay JO, et al. Among authors: fayette j. Int J Cancer. 2006 Aug 1;119(3):706-11. doi: 10.1002/ijc.21867. Int J Cancer. 2006. PMID: 16496406 Clinical Trial.
ET-743: a novel agent with activity in soft-tissue sarcomas.
Fayette J, Coquard IR, Alberti L, Boyle H, Méeus P, Decouvelaere AV, Thiesse P, Sunyach MP, Ranchère D, Blay JY. Fayette J, et al. Curr Opin Oncol. 2006 Jul;18(4):347-53. doi: 10.1097/01.cco.0000228740.70379.3f. Curr Opin Oncol. 2006. PMID: 16721129 Review.
160 results